NCT03584165: Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa
- State
- Completed
- Phase
- Phase 3
- People
- 277 taking part
- Started
- 4 Jun 2018
- Primary completion
- 22 Jun 2026
- Arms
- BIIB112
- Results
- None posted
- 4 Jun 2018: Trial started
- 12 Jul 2018: Trial registered
- 22 Jun 2026: Trial completed